Gerard Acloque
Internal Medicine · Hollywood, FLNPI 1154687507
Payments from drug & device makers
What this record shows
12 manufacturers reported payments, led by Shionogi Inc at 59.0% of the total. Reporting peaked in 2023 at $1,772 and has fallen 90.6% since, to $167 in 2025.
Across 20 payments — averaging $124.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shionogi Inc$1K
- Boehringer Ingelheim$161
- Heartflow, Inc.$146
- AstraZeneca$143
- E.r. Squibb & Sons, L.L.C.$141
- Medtronic$125
- plus $306 from 6 others
Across 462 payments — averaging $31,310 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$11.2M
- Exeltis, USA Inc.$1.8M
- GSK$474K
- Sanofi US Services Inc.$387K
- AbbVie$284K
- Taro Pharmaceuticals USA, Inc.$163K
- plus $200K from 3 others
What the payments were for
- Travel & lodging$1,16447%
- Food & beverage$1,32753%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shionogi Inc | 3 | $1,469 |
| Boehringer Ingelheim | 3 | $161 |
| Heartflow, Inc. | 1 | $146 |
| AstraZeneca | 2 | $143 |
| E.r. Squibb & Sons, L.L.C. | 1 | $141 |
| Medtronic | 1 | $125 |
| Viiv Healthcare Company | 1 | $125 |
| Lilly USA, LLC | 3 | $58 |
| Exact Sciences | 2 | $44 |
| Pfizer | 1 | $39 |
| Abbott | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,491 in reported general payments places this provider in the 80th percentile of 8,530 internal medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 12 | $13,164 |
| Atorvastatin Calcium | 52 | $624 |
| Rosuvastatin Calcium | 34 | $569 |
| Amlodipine Besylate | 37 | $385 |
| Losartan Potassium | 29 | $292 |
| Levothyroxine Sodium | 30 | $279 |
| Lisinopril | 38 | $223 |
| Nifedipine ErNifedipine | 12 | $218 |
| Omeprazole | 11 | $198 |
| Chlorthalidone | 19 | $195 |
| Pantoprazole Sodium | 19 | $183 |
| Metoprolol Tartrate | 20 | $172 |
| Labetalol Hcl | 12 | $138 |
| Gabapentin | 22 | $133 |
| Hydralazine Hcl | 12 | $116 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Hollywood
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
- Bianka EperjesiovaGainesville$260K
- Julio ConradoFort Myers$247K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.